| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |